Neumora Therapeutics (NMRA) Market Capitalization (2023 - 2026)

Neumora Therapeutics (NMRA) Market Capitalization (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn
9 Abivax 90.15 Bn 90.15 Bn -
10 Neumora Therapeutics 320.17 Mn 320.17 Mn -

Historic Data

Download Data
DateValue
Jun 12, 2026 320.17 Mn
Jun 11, 2026 318.37 Mn
Jun 10, 2026 285.10 Mn
Jun 9, 2026 296.79 Mn
Jun 8, 2026 290.49 Mn
Jun 5, 2026 293.19 Mn
Jun 4, 2026 314.78 Mn
Jun 3, 2026 312.98 Mn
Jun 2, 2026 315.68 Mn
Jun 1, 2026 328.27 Mn
May 29, 2026 332.76 Mn
May 28, 2026 338.16 Mn
May 27, 2026 334.56 Mn
May 26, 2026 330.07 Mn
May 22, 2026 332.76 Mn
May 21, 2026 332.76 Mn
May 20, 2026 307.58 Mn
May 19, 2026 300.39 Mn
May 18, 2026 318.37 Mn
May 15, 2026 330.96 Mn